Astragen
Training
Clinical Trials
Pharmacogenomics
Astragen Media
Publications
Presentations
Press Releases
About Us
Contact Us
e-mail me

Presentations
 

Speaker: Mid-Atlantic Yeast Genetics Meeting. Neerja Sethi, C. Monteagudo, D. Koshland, and Dan Burke. 1990. Genetic And Sequence Analysis of CDC20 In S. cerevisiae.

 

Speaker: Cold Spring Harbor Laboratory, Cell Biology Meeting. Neerja Sethi, C. Monteagudo, D. Koshland, and D. Burke. 1991. The CDC20 Gene of S. cerevisiae Encodes A Beta-Transducin Homolog And Is Required To Execute The Essential Microtubule-Dependent Step.

 

Poster: Yeast Genetics and Molecular Biology Meeting, San Francisco. Dan Burke, Neerja Sethi, C. Monteagudo, and D. Koshland. 1992. The CDC20 Gene of S. cerevisiae Is Required For Microtubule Disassembly and Has Homology To The Beta-Subunit of Transducin.

 

Poster: American Society of Microbiology Meeting, Washington DC. K. N. Vithalani, J. D. Shoffner, N. Sethi, C. G. Burns, and A. DeLozanne. 1993. Dictyostelium Mutants Defective In Cytokinesis And Cell Motility.

 

Poster: American Society of Microbiology Meeting. San Francisco. Neerja Sethi and Arturo DeLozanne. 1994. Identification Of A Novel Gene Involved In Development And Cell Motility In Dictyostelium.

 

Invited Speaker: Swiss Tropical Institute, Basel, Switzerland. Neerja Sethi. 1995. Molecular Genetic Analysis of The Eukaryotic Cell Cycle.

 

Poster: 6th European Cooperation In The Field Of Scientific and Technical Research (COST) Congress on Antiparasitic Chemotherapy, Brussels, Belgium.R. Kaminsky, N. Sethi, P. Maeser. 1997. Identification of Drug-Resistance Mediating Genes In Trypanosoma brucei spp.

 

Speaker: Fourth International AIDS Malignancy Conference, NIH. Neerja Sethi and Joel Palefsky. 2000. Treatment of Human Papillomavirus (HPV) Type 16 Virus-Infected Cells Using the Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene.

 

Speaker: 18th International Papillomavirus Conference, Barcelona, Spain. Neerja Sethi and Joel Palefsky. 2000. Treatment of Human Papillomavirus (HPV) Type 16 Virus-Infected Cells Using the Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene.

 

Speaker: 19th International Papillomavirus Conference, Florianopolis, Brazil. Neerja Sethi and Joel Palefsky. 2001. Virus Specific Treatment of Human Papillomavirus (HPV) Type 16 Virus-Infected Cells Using the Herpes Simplex Virus Thymidine Kinase (HSV1-TK) Gene.

 

Speaker: 20th International Papillomavirus Conference, Pasteur Institute, Paris. Neerja Sethi and Joel Palefsky. 2002. Clinical Applications for HPV16 E2 Regulated, HSV1-TK Mediated Gene Therapy using Topically Applied Liposomes for Gene Delivery.

 

Participant: 7th International Biotech Summit, University of California San Francisco, May 2003. Neerja Sethi and Joel Palefsky. 2003. Virus-Specific Diagnostic and Therapeutic Strategies using Non-viral Vector Systems for Gene Delivery with Enhanced Safety and Efficacy.

 

Participant: BioPharm Summit on Drug Development and Clinical Trials, Four Seasons Hotel, San Francisco, October 2003.

 

Organizer: The 2005 Stem Cells Symposium, San Francicso, California. http://www.medicineandbiotech.org



 


|Astragen| |Training| |Clinical Trials| |Pharmacogenomics| |Astragen Media| |Publications| |Presentations| |Press Releases| |About Us| |Contact Us|